NO20052310L - Posisjonsisomerer av PEG IFN alfa 2A. - Google Patents
Posisjonsisomerer av PEG IFN alfa 2A.Info
- Publication number
- NO20052310L NO20052310L NO20052310A NO20052310A NO20052310L NO 20052310 L NO20052310 L NO 20052310L NO 20052310 A NO20052310 A NO 20052310A NO 20052310 A NO20052310 A NO 20052310A NO 20052310 L NO20052310 L NO 20052310L
- Authority
- NO
- Norway
- Prior art keywords
- position isomers
- peg ifn
- ifn alfa
- alfa
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02025585 | 2002-11-15 | ||
| PCT/EP2003/012498 WO2004045648A1 (en) | 2002-11-15 | 2003-11-10 | Positional isomers of peg ifn alpha 2a |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052310D0 NO20052310D0 (no) | 2005-05-11 |
| NO20052310L true NO20052310L (no) | 2005-08-09 |
Family
ID=32319537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052310A NO20052310L (no) | 2002-11-15 | 2005-05-11 | Posisjonsisomerer av PEG IFN alfa 2A. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20040223950A1 (ja) |
| EP (1) | EP1562634B1 (ja) |
| JP (1) | JP4279258B2 (ja) |
| KR (1) | KR20050065677A (ja) |
| CN (1) | CN1323722C (ja) |
| AR (1) | AR042039A1 (ja) |
| AT (1) | ATE337017T1 (ja) |
| AU (1) | AU2003293668A1 (ja) |
| BR (1) | BR0316227A (ja) |
| CA (1) | CA2503594C (ja) |
| DE (1) | DE60307881T2 (ja) |
| ES (1) | ES2270152T3 (ja) |
| GT (1) | GT200300244A (ja) |
| MX (1) | MXPA05005178A (ja) |
| NO (1) | NO20052310L (ja) |
| PA (1) | PA8587801A1 (ja) |
| PE (1) | PE20040834A1 (ja) |
| PL (1) | PL376883A1 (ja) |
| RU (1) | RU2005118752A (ja) |
| TW (1) | TW200413404A (ja) |
| UY (1) | UY28080A1 (ja) |
| WO (1) | WO2004045648A1 (ja) |
| ZA (1) | ZA200503756B (ja) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| CA2504267A1 (en) * | 2002-11-18 | 2004-06-03 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| AU2008201682B2 (en) * | 2004-02-02 | 2011-02-24 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
| WO2005074650A2 (en) | 2004-02-02 | 2005-08-18 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
| JP2008507298A (ja) | 2004-05-19 | 2008-03-13 | マキシジェン， インコーポレイテッド | インターフェロンαポリペプチドおよび結合体 |
| KR20080019619A (ko) | 2005-05-18 | 2008-03-04 | 맥시겐, 인크. | 개량된 인터페론-알파 폴리펩티드 |
| US7695710B2 (en) | 2005-06-20 | 2010-04-13 | Pepgen Corporation | Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs |
| KR20080037656A (ko) * | 2005-06-20 | 2008-04-30 | 펩젠 코포레이션 | 저독성의 장시간 순환하는 사람 인터페론-알파 유사체 및인터페론 타우의 키메라 |
| CN101002944B (zh) * | 2006-01-17 | 2012-07-25 | 中国科学院过程工程研究所 | 支链聚乙二醇-干扰素结合物及其制备方法 |
| AR078117A1 (es) * | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
| CA2698396C (en) * | 2007-09-04 | 2014-01-21 | Biosteed Gene Expression Tech. Co., Ltd. | Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| EP2186830B1 (en) * | 2007-09-04 | 2012-03-07 | Biosteed Gene Expression Tech. CO., LTD. | Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| CA2720306C (en) | 2008-04-03 | 2016-03-15 | Biosteed Gene Expression Tech. Co., Ltd. | Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| EP2113256A1 (en) | 2008-04-29 | 2009-11-04 | Ascendis Pharma AS | PEGylated rhGH compounds |
| PT3050576T (pt) | 2008-04-29 | 2021-06-01 | Ascendis Pharma Growth Disorders Div A/S | Compostos recombinantes e peguilados da hormona de crescimento humana |
| DE102009009344B4 (de) * | 2009-02-05 | 2018-01-04 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Verfahren und Anordnung zur Reinigung des Reaktionsgemisches bei der Herstellung von Radiopharmaka |
| US8623348B2 (en) * | 2009-03-27 | 2014-01-07 | Jw Pharmaceutical Corporation | Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP) |
| CN101514229B (zh) * | 2009-04-03 | 2012-05-09 | 海南四环心脑血管药物研究院有限公司 | 人干扰素α衍生物及其聚乙二醇化修饰物 |
| CN106749608B (zh) * | 2015-11-18 | 2021-10-15 | 石药集团中奇制药技术（石家庄）有限公司 | 干扰素α缀合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5951974A (en) * | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
| WO2004021993A2 (en) * | 2002-09-05 | 2004-03-18 | The General Hospital Corporation | Modified asialo-interferons and uses thereof |
-
2003
- 2003-11-10 RU RU2005118752/04A patent/RU2005118752A/ru not_active Application Discontinuation
- 2003-11-10 DE DE60307881T patent/DE60307881T2/de not_active Expired - Lifetime
- 2003-11-10 WO PCT/EP2003/012498 patent/WO2004045648A1/en active IP Right Grant
- 2003-11-10 PL PL376883A patent/PL376883A1/pl not_active Application Discontinuation
- 2003-11-10 AT AT03789020T patent/ATE337017T1/de not_active IP Right Cessation
- 2003-11-10 CA CA2503594A patent/CA2503594C/en not_active Expired - Fee Related
- 2003-11-10 BR BR0316227-3A patent/BR0316227A/pt not_active Application Discontinuation
- 2003-11-10 AU AU2003293668A patent/AU2003293668A1/en not_active Abandoned
- 2003-11-10 EP EP03789020A patent/EP1562634B1/en not_active Expired - Lifetime
- 2003-11-10 ES ES03789020T patent/ES2270152T3/es not_active Expired - Lifetime
- 2003-11-10 MX MXPA05005178A patent/MXPA05005178A/es unknown
- 2003-11-10 CN CNB2003801033411A patent/CN1323722C/zh not_active Expired - Lifetime
- 2003-11-10 KR KR1020057008685A patent/KR20050065677A/ko not_active Application Discontinuation
- 2003-11-10 JP JP2004552547A patent/JP4279258B2/ja not_active Expired - Lifetime
- 2003-11-12 PA PA20038587801A patent/PA8587801A1/es unknown
- 2003-11-12 TW TW092131686A patent/TW200413404A/zh unknown
- 2003-11-13 GT GT200300244A patent/GT200300244A/es unknown
- 2003-11-13 AR ARP030104175A patent/AR042039A1/es unknown
- 2003-11-13 PE PE2003001148A patent/PE20040834A1/es not_active Application Discontinuation
- 2003-11-13 US US10/712,494 patent/US20040223950A1/en not_active Abandoned
- 2003-11-13 UY UY28080A patent/UY28080A1/es not_active Application Discontinuation
-
2005
- 2005-05-10 ZA ZA200503756A patent/ZA200503756B/xx unknown
- 2005-05-11 NO NO20052310A patent/NO20052310L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05005178A (es) | 2005-07-22 |
| CA2503594A1 (en) | 2004-06-03 |
| ATE337017T1 (de) | 2006-09-15 |
| DE60307881D1 (de) | 2006-10-05 |
| EP1562634A1 (en) | 2005-08-17 |
| WO2004045648A1 (en) | 2004-06-03 |
| UY28080A1 (es) | 2004-05-31 |
| JP4279258B2 (ja) | 2009-06-17 |
| BR0316227A (pt) | 2005-10-04 |
| AR042039A1 (es) | 2005-06-08 |
| PE20040834A1 (es) | 2004-11-17 |
| KR20050065677A (ko) | 2005-06-29 |
| US20040223950A1 (en) | 2004-11-11 |
| GT200300244A (es) | 2004-06-03 |
| CN1711109A (zh) | 2005-12-21 |
| PL376883A1 (pl) | 2006-01-09 |
| TW200413404A (en) | 2004-08-01 |
| EP1562634B1 (en) | 2006-08-23 |
| PA8587801A1 (es) | 2004-09-16 |
| CN1323722C (zh) | 2007-07-04 |
| NO20052310D0 (no) | 2005-05-11 |
| RU2005118752A (ru) | 2006-02-10 |
| ES2270152T3 (es) | 2007-04-01 |
| AU2003293668A1 (en) | 2004-06-15 |
| CA2503594C (en) | 2011-05-10 |
| DE60307881T2 (de) | 2007-03-08 |
| JP2006515571A (ja) | 2006-06-01 |
| ZA200503756B (en) | 2008-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052310L (no) | Posisjonsisomerer av PEG IFN alfa 2A. | |
| DE60311272D1 (de) | Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten | |
| BRPI0411900B8 (pt) | compostos e composições farmacêuticas compreendendo os mesmos | |
| TW200510343A (en) | Substituted dihydroquinazolines | |
| FR16C0028I2 (fr) | Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques | |
| BR122020006906B8 (pt) | compostos e composições farmacêuticas antivirais | |
| WO2004014312A3 (en) | Small-mer compositions and methods of use | |
| ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
| TW200633718A (en) | Treatment of hepatitis c in the asian population | |
| CY2014019I2 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| BRPI0416936A (pt) | sistemas de anel de imidazo substituìdos e métodos | |
| NO20053817D0 (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
| WO2005002526A3 (en) | Method and compositions for treatment of viral infections | |
| NO20033123D0 (no) | Terapeutisk hinnedannende sammensetning og behandlingsplan derav | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| HK1097467A1 (en) | Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids | |
| ATE455789T1 (de) | Substituierte nonadepsipeptide | |
| DK1476467T3 (da) | IgG3-immunglobulin som beskyttelsesmarkör mod virusinfektionssygdomme og anvendelser deraf | |
| ECSP034872A (es) | Nuevos heterociclos 3 | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| DE60231605D1 (de) | Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen | |
| DK1474415T3 (da) | 1-phenyl-2-heteroaryl-substituerede benzimidazolderivater, deres anvendelse til fremstilling af lægemidler til behandling af immunologiske sygdomme | |
| DK1299350T3 (da) | Substituerede benzamider til styrket immunforsvar og behandling af kræft, infektioner og manio-depressive sygdomme | |
| UY27348A1 (es) | Imidazotriazinas |